Inventor · disambiguated record
Wilfred Jefferies
Also filed as: JEFFERIES WILFRED · JEFFERIES WILFRED A · JEFFERIES WILFRED ARTHUR
12 granted patents·27 pending applications·257 citations·filing 1995–2023
90Inventor score
Files withUNIV BRITISH COLUMBIA12TAPIMMUNE INC7JEFFERIES WILFRED5MYND LIFE SCIENCES INC5BIOASIS TECHNOLOGIES INC2
Top patents by PatentIndex Score
39 records- 0192US7378087B2Method of enhancing an immune responseTAPIMMUNE INC·Filed 2002·Granted May 27, 2008·63 cites·7 claims
- 0290US5981194AUse of p97 and iron binding proteins as diagnostic and therapeutic agentsUNIV BRITISH COLUMBIA·Filed 1995·Granted Nov 9, 1999·109 cites·10 claims
- 0386US6455494B1Use of p97 and iron binding proteins as diagnostic and therapeutic agentsUNIV BRITISH COLUMBIA·Filed 1999·Granted Sep 24, 2002·70 cites·7 claims
- 0475US11492400B2Antibodies to L-type voltage gated channels and related methodsUNIV BRITISH COLUMBIA·Filed 2020·Granted Nov 8, 2022·1 cites·1 claims
- 0570US12077582B2Antibodies to L-type voltage gated channels and related methodsUNIV BRITISH COLUMBIA·Filed 2022·Granted Sep 3, 2024·0 cites·1 claims
- 0662US2024254515A1Flexible expression vector systems and application of same to vaccines and immunotherapeuticsUNIV BRITISH COLUMBIA·Filed 2022·Application pending·0 cites
- 0762US2015093399A1Cns-targeted conjugates having modified fc regions and methods of use thereofBIOASIS TECHNOLOGIES INC·Filed 2014·Application pending·0 cites
- 0862US2024238409A1Sars-cov-2 multi-epitope vaccinesUNIV BRITISH COLUMBIA·Filed 2022·Application pending·0 cites
- 0962US2023402129A1A method of epitope-based vaccine designUNIV BRITISH COLUMBIA·Filed 2021·Application pending·0 cites
- 1061US7994146B2Method of enhancing an immune responseTAPIMMUNE INC·Filed 2008·Granted Aug 9, 2011·0 cites·10 claims
- 1161US2025090554A1A method of treating depression by immune modulationMYND LIFE SCIENCES INC·Filed 2022·Application pending·0 cites
- 1261US2025327140A1A method of determining the dose of psychedelicsMYND LIFE SCIENCES INC·Filed 2023·Application pending·0 cites
- 1360US11925678B2Methods for diagnosing and treating Alzheimer's diseaseCAVA HEALTHCARE INC·Filed 2020·Granted Mar 12, 2024·0 cites·10 claims
- 1459US2022226440A1Modulation of cancer immunity with type 2 innate lymphoid cells, interleukin 33, and/or interferon induced protein 44CAVA HEALTHCARE INC·Filed 2021·Application pending·0 cites
- 1558US2025281513A1Use of psychedelics to treat dementiaMYND LIFE SCIENCES INC·Filed 2022·Application pending·0 cites
- 1657US10792347B2Methods for diagnosing and treating Alzheimer's diseaseJEFFERIES WILFRED·Filed 2017·Granted Oct 6, 2020·0 cites·5 claims
- 1757US2025320557A1Use of abcf1 in methods of diagnosing and monitoring inflammatory and/or autoimmune diseaseMYND LIFE SCIENCES INC·Filed 2022·Application pending·0 cites
- 1856US7976850B2Pox viridae treatmentTAPIMMUNE INC·Filed 2009·Granted Jul 12, 2011·0 cites·1 claims
- 1956US2023405026A1A Method of Treating Depression by Immune ModulationMYND LIFE SCIENCES INC·Filed 2021·Application pending·0 cites
- 2056US2025179212A1Methods of treating cancer and monitoring cancer progressionUNIV BRITISH COLUMBIA·Filed 2023·Application pending·0 cites
- 2156US2023310585A1Vaccine for viral pathogensUNIV BRITISH COLUMBIA·Filed 2021·Application pending·0 cites
- 2253US2023210832A1Methods for treating alzheimer's diseaseJEFFERIES WILFRED·Filed 2021·Application pending·0 cites
- 2353US2010322963A1Low dose inoculation with tap for anti-tumor immunityTAPIMMUNE INC·Filed 2009·Application pending·0 cites
- 2451US2011117137A1Tapasin augmentation for enhanced immune responseTAPIMMUNE INC·Filed 2009·Application pending·0 cites
- 2551US2021038559A1Cannabinoids and derivatives for promoting immunogenicity of tumor and infected cellsGADEK THOMAS RICHARD·Filed 2019·Application pending·0 cites
- 2651US2012135031A1Method of enhancing an immune responseJEFFERIES WILFRED ARTHUR·Filed 2011·Application pending·0 cites
- 2750US11213571B2Modulation of cancer immunity with type 2 innate lymphoid cells, interleukin 33, and/or interferon induced protein 44JEFFERIES WILFRED·Filed 2016·Granted Jan 4, 2022·0 cites·12 claims
- 2849US5792604AMethod of identifying MHC-class I restricted antigens endogenously processed by cellular secretory pathwayUNIV BRITISH COLUMBIA·Filed 1996·Granted Aug 11, 1998·8 cites·21 claims
- 2948US6361770B1Method of enhancing expression of MHC class I molecules bearing endogenous peptidesUNIV BRITISH COLUMBIA·Filed 1995·Granted Mar 26, 2002·6 cites·10 claims
- 3048US2019192683A1Cns-targeted conjugates having modified fc regions and methods of use thereofBIOASIS TECHNOLOGIES INC·Filed 2017·Application pending·0 cites
- 3146US2003077693A1Use of p97 and iron binding proteins as diagnostic and therapeutic agentsUNIV BRITISH COLUMBIA·Filed 2002·Application pending·0 cites
- 3244US2010166781A1Hat acetylation promoters and uses of compositions thereof in promoting immunogenicityTAPIMMUNE INC·Filed 2009·Application pending·0 cites
- 3343US2011212131A1Method for enhancing an immune responseTAPIMMUNE INC·Filed 2011·Application pending·0 cites
- 3443US2014294726A1Methods for diagnosing and treating alzheimer's disease by administering an anti-angiogenic agentJEFFERIES WILFRED·Filed 2012·Application pending·0 cites
- 3542US2022125876A1A method of immune modulation by modulating abcf1PACIFIC MYCO BIOSCIENCES LTD·Filed 2020·Application pending·0 cites
- 3639US2004055022A1Compositions and methods for screening therapeutic agentsFiled 2001·Application pending·0 cites
- 3737US2018022803A1Antibodies to l-type voltage gated channels and related methodsBIOMMUNE TECH INC·Filed 2016·Application pending·0 cites
- 3836US2016194393A1Methods and compositions for modulating voltage-gated calcium channel functionJEFFERIES WILFRED A·Filed 2012·Application pending·0 cites
- 3930US2015283226A1Compositions and methods of modulating an immune responseJEFFERIES WILFRED·Filed 2012·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →